Skip to main content
. 2011 Jul 7;7:409–414. doi: 10.2147/NDT.S14208

Table 2.

Summary of common adverse events (>10% of patients) reported in ezogabine-treated patients from randomized, double-blind, placebo-controlled trials as adjunctive treatment of refractory partial seizures in adults

Dizziness
Somnolence
Fatigue
Confusion
Headache
Dysarthria
Tremor
Vertigo
Ataxia
Amnesia
Thinking abnormal
Speech disorder
Blurry vision
Asthenia
Nausea
Urinary tract infection

Source: Porter et al,23 Brodie et al,24 French et al.25